Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Standards for nanomaterials and cardiac valve prostheses make the grade in US

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration has made 20 new entries to its list of recognized medical device standards for use in pre-market reviews1. Other changes to the list include the withdrawal of standards and their replacement by others where applicable, correction of errors in previously recognized standards, and changes to the supplementary information sheets of recognized standards that describe revisions to the applicability of the standards.

You may also be interested in...



US FDA Encourages Broader Use of Popular IVD Coding Standard, Cautions Off-Label Use

Three years after recognizing a widely used coding standard for in vitro diagnostics, FDA appears to be encouraging broader adoption of the codes. It issued a guidance on when it will accept the codes while cautioning against their use for unapproved or uncleared uses.

EU Panel Outlines Practical Way Forward With Big Data

An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.

Switzerland Fast Tracks Registration Of EU/US-Approved Anti-Infectives

Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.

UsernamePublicRestriction

Register

MT040443

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel